The effectiveness of cyclogest and duphaston in supporting the luteal phase of infertility patients

Phase 2

• Conditions: Female infertility.; Female infertility, unspecified; N97.9

• Registration Number: IRCT20200825048515N32
• Lead Sponsor: Esfahan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 26 May 2021

Recruitment & Eligibility

• Status: Pending
• Sex: Female
• Target Recruitment: 100

Inclusion Criteria

Age 40-20 years old
History of infertility and candidate for IVF treatment
Normal endometrial thickness (7 to 12 mm)
Consent to participate in the study

Exclusion Criteria

Having pelvic density adhesion
Having advanced endometriosis
Having genital tuberculosis

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Clinical pregnancy rate. Timepoint: Five weeks after the start of the intervention. Method of measurement: Vaginal ultrasound of the uterus.;Chemical pregnancy. Timepoint: Two weeks after embryo transfer. Method of measurement: Laboratory kit.;Beta human chorionic gonadotropin(Beta-HCG). Timepoint: Two weeks after embryo transfer. Method of measurement: Blood test.